Search

everythinglearnresearchcommunity

for

Search:↓

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Men with enlarged prostates often have more severe baldness.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Finasteride effectively treats male hair loss, increasing length and thickness.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The healthcare for transgender veterans could be better with a more unified team approach.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.